HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Srinivasan Madhusudan Selected Research

Fatigue

1/2017Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.
8/2015Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.
7/2014Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Srinivasan Madhusudan Research Topics

Disease

68Neoplasms (Cancer)
05/2024 - 08/2002
37Breast Neoplasms (Breast Cancer)
01/2023 - 10/2003
19Ovarian Neoplasms (Ovarian Cancer)
04/2024 - 09/2005
14Ovarian Epithelial Carcinoma
04/2024 - 10/2014
9Disease Progression
01/2022 - 10/2004
7Ataxia Telangiectasia (Louis Bar Syndrome)
05/2019 - 01/2013
7Adenocarcinoma
10/2018 - 10/2009
6Genomic Instability
01/2021 - 05/2014
5Prostatic Neoplasms (Prostate Cancer)
01/2023 - 01/2022
5Neutropenia
12/2022 - 04/2010
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 11/2012
5Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2018 - 04/2010
4Noninfiltrating Intraductal Carcinoma (DCIS)
05/2024 - 12/2018
3Carcinogenesis
03/2023 - 07/2004
3Infections
12/2022 - 04/2010
3Stomach Neoplasms (Stomach Cancer)
01/2020 - 06/2013
3Neoplasm Metastasis (Metastasis)
06/2019 - 01/2016
3Fatigue
01/2017 - 07/2014
3Glioblastoma (Glioblastoma Multiforme)
05/2015 - 01/2010
3Glioma (Gliomas)
01/2015 - 01/2010
3Melanoma (Melanoma, Malignant)
05/2014 - 05/2003
2Retinoblastoma (Glioblastoma, Retinal)
04/2024 - 03/2014
2Hypersensitivity (Allergy)
11/2023 - 03/2013
2Triple Negative Breast Neoplasms
09/2023 - 01/2020
2Febrile Neutropenia
12/2022 - 01/2014
2Breast Ductal Carcinoma
11/2021 - 07/2021
2Werner Syndrome (Werner's Syndrome)
01/2021 - 03/2016
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 07/2015
2Ataxia (Dyssynergia)
10/2019 - 03/2013
2Hypertension (High Blood Pressure)
01/2017 - 08/2015
2Carcinoma (Carcinomatosis)
01/2017 - 11/2012
2Inflammation (Inflammations)
10/2016 - 09/2005
2Pain (Aches)
07/2014 - 01/2014
2Abdominal Pain (Pain, Abdominal)
01/2014 - 05/2004
2Cholangiocarcinoma
04/2010 - 01/2010

Drug/Important Bio-Agent (IBA)

36Proteins (Proteins, Gene)FDA Link
05/2024 - 12/2005
21DNA (Deoxyribonucleic Acid)IBA
11/2021 - 05/2004
20PlatinumIBA
04/2024 - 10/2009
18Messenger RNA (mRNA)IBA
09/2023 - 01/2012
14Cisplatin (Platino)FDA LinkGeneric
04/2021 - 10/2003
14Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2013
9lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
11/2021 - 03/2013
8Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2023 - 01/2015
6RecQ HelicasesIBA
12/2023 - 01/2016
6Estrogen ReceptorsIBA
01/2021 - 03/2013
6GemcitabineFDA Link
01/2017 - 01/2010
5Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2023 - 12/2014
4Flap EndonucleasesIBA
07/2021 - 06/2013
4olaparibIBA
01/2020 - 12/2018
4Phosphotransferases (Kinase)IBA
05/2019 - 07/2004
4EndonucleasesIBA
08/2015 - 02/2014
3Phenobarbital (Luminal)FDA Link
09/2023 - 12/2014
3MethyltransferasesIBA
10/2022 - 01/2011
3DNA HelicasesIBA
11/2021 - 01/2021
3DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2021 - 05/2014
3Poly (ADP-Ribose) Polymerase-1IBA
01/2020 - 01/2015
3TensinsIBA
10/2019 - 05/2014
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2019 - 05/2014
3AnthracyclinesIBA
08/2019 - 11/2014
3Alkylating AgentsIBA
09/2017 - 01/2010
3Tyrosine Kinase InhibitorsIBA
01/2017 - 07/2004
3EnzymesIBA
08/2015 - 01/2010
3DNA-Activated Protein KinaseIBA
12/2014 - 07/2014
2Cyclin-Dependent Kinases (cdk Proteins)IBA
04/2024 - 06/2018
26- (4- hydroxyphenyl)- 2- thioxo- 2,3- dihydro- 4(1H)- pyrimidinoneIBA
06/2023 - 07/2022
2taxaneIBA
01/2023 - 08/2019
2Androgen Receptors (Androgen Receptor)IBA
01/2023 - 10/2022
2AndrogensIBA
10/2022 - 01/2022
26-methyladenineIBA
10/2022 - 01/2022
2RNA (Ribonucleic Acid)IBA
10/2022 - 01/2022
2Hormones (Hormone)IBA
01/2022 - 03/2013
2Estrogens (Estrogen)FDA Link
01/2021 - 12/2014
2Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2021 - 03/2016
2EpitopesIBA
01/2020 - 07/2015
2Monoclonal AntibodiesIBA
01/2020 - 07/2015
2Polysaccharides (Glycans)IBA
01/2020 - 07/2015
2Keratin-18 (Keratin 18)IBA
01/2018 - 04/2012
2cediranib (AZD2171)IBA
01/2018 - 08/2015
2Serine (L-Serine)FDA Link
02/2016 - 03/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2015 - 05/2003
2CaspasesIBA
07/2015 - 04/2012
2Ataxia Telangiectasia Mutated ProteinsIBA
12/2014 - 11/2014
2X-ray Repair Cross Complementing Protein 1IBA
12/2014 - 06/2013
2DNA-(Apurinic or Apyrimidinic Site) Lyase (AP Endonuclease)IBA
12/2014 - 08/2010
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2014 - 02/2005
2Uracil-DNA GlycosidaseIBA
12/2013 - 06/2013
2calpastatinIBA
11/2013 - 11/2012
2CalpainIBA
11/2013 - 11/2012
2Temozolomide (Temodar)FDA LinkGeneric
01/2011 - 01/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2005 - 10/2004
2Etanercept (Enbrel)FDA Link
09/2005 - 10/2004
1Cyclin-Dependent Kinase 2IBA
05/2024
1CyclinsIBA
04/2024
1Cyclin D1IBA
04/2024
1arseniteIBA
11/2023

Therapy/Procedure

46Therapeutics
04/2024 - 08/2002
28Drug Therapy (Chemotherapy)
04/2023 - 05/2004
5Radiotherapy
12/2022 - 01/2007
4Neoadjuvant Therapy
06/2017 - 10/2009
3Adjuvant Chemotherapy
06/2017 - 11/2013